Attendee search 

Ethypharm is a rapidly growing specialty pharma company with nascent commercial operations, an expanding portfolio of marketed products, a unique drug development expertise and a broad and advanced pipeline.

Ethypharm now incorporating Martindale Pharma of the UK focuses on pain management and treatment for addiction, particularly opioids and alcohol use disorder; with the current short-term goal to commercialize its own or in-licensed drugs in a number of European countries.

In other therapeutic areas, mainly oncology, Ethypharm has a strong capability in developing and manufacturing specific and "complex" drug formulations in order to market them through global or local partners.

Ethypharm’s headquarters are located in Paris, France and has a very strong affiliate in the UK, it owns two manufacturing plants in France, one in China, and an affiliate in the USA.
 
Ethypharm is actively seeking:

• Licensing-in/acquisition opportunities in pain and addiction (to opioids, alcohol, tobacco) , critical care, complex generics, brands, late stage NCEs, Steriles/Injectables, Hospital products);